Literature DB >> 19585236

Controversial BRCA1 allelotypes in commonly used breast cancer cell lines.

Sivasundaram Karnan, Morassa Mohseni, Yuko Konishi, Akina Tamaki, Yoshitaka Hosokawa, Ben H Park, Hiroyuki Konishi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19585236      PMCID： PMC2805406          DOI： 10.1007/s10549-009-0465-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  13 in total

1.  Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA.

Authors:  Christos Kroupis; Aliki Stathopoulou; Eleni Zygalaki; Lisa Ferekidou; Maroulio Talieri; Evi S Lianidou
Journal:  Clin Biochem       Date:  2005-01       Impact factor: 3.281

2.  c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.

Authors:  Y Chai; G Chipitsyna; J Cui; B Liao; S Liu; K Aysola; M Yezdani; E S Reddy; V N Rao
Journal:  Oncogene       Date:  2001-03-15       Impact factor: 9.867

3.  Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.

Authors:  D A Favy; P Rio; J C Maurizis; C Hizel; Y J Bignon; D J Bernard-Gallon
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

4.  Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.

Authors:  S Kytölä; J Rummukainen; A Nordgren; R Karhu; F Farnebo; J Isola; C Larsson
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

5.  Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation.

Authors:  Kristina Trenz; Julia Landgraf; Günter Speit
Journal:  Breast Cancer Res Treat       Date:  2003-03       Impact factor: 4.872

6.  Induction and processing of complex DNA damage in human breast cancer cells MCF-7 and nonmalignant MCF-10A cells.

Authors:  Dave C Francisco; Prakash Peddi; Jessica M Hair; Brittany A Flood; Angela M Cecil; Peter T Kalogerinis; George Sigounas; Alexandros G Georgakilas
Journal:  Free Radic Biol Med       Date:  2007-11-20       Impact factor: 7.376

7.  Growth retardation and tumour inhibition by BRCA1.

Authors:  J T Holt; M E Thompson; C Szabo; C Robinson-Benion; C L Arteaga; M C King; R A Jensen
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

8.  Karyotypic complexity of the NCI-60 drug-screening panel.

Authors:  Anna V Roschke; Giovanni Tonon; Kristen S Gehlhaus; Nicolas McTyre; Kimberly J Bussey; Samir Lababidi; Dominic A Scudiero; John N Weinstein; Ilan R Kirsch
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

9.  BRCA1 suppresses osteopontin-mediated breast cancer.

Authors:  Mohamed K El-Tanani; Frederick Charles Campbell; Paul Crowe; Pauline Erwin; Denis Paul Harkin; Paul Pharoah; Bruce Ponder; Philip S Rudland
Journal:  J Biol Chem       Date:  2006-06-28       Impact factor: 5.157

10.  Molecular cytogenetic analysis of breast cancer cell lines.

Authors:  J M Davidson; K L Gorringe; S F Chin; B Orsetti; C Besret; C Courtay-Cahen; I Roberts; C Theillet; C Caldas; P A Edwards
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640
View more
  1 in total

1.  Analysis of BRCA2 loss of heterozygosity in tumor tissue using droplet digital polymerase chain reaction.

Authors:  Rory L Cochran; Karen Cravero; David Chu; Bracha Erlanger; Patricia Valda Toro; Julia A Beaver; Daniel J Zabransky; Hong Yuen Wong; Justin Cidado; Sarah Croessmann; Heather Parsons; Minsoo Kim; Sarah J Wheelan; Pedram Argani; Ben Ho Park
Journal:  Hum Pathol       Date:  2014-04-13       Impact factor: 3.466
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.